Please login to the form below

Not currently logged in

Chugai Pharma

This page shows the latest Chugai Pharma news and features for those working in and with pharma, biotech and healthcare.

Chugai soars on Roche buyout rumours

Chugai soars on Roche buyout rumours

Chugai soars on Roche buyout rumours. Reports circulating that Swiss company is poised to make $10bn offer. ... Shares in Japanese pharma company Chugai are riding high amid growing speculation that Roche is poised to buy out the firm.

Latest news

  • Chugai appoints US CMO Chugai appoints US CMO

    Japanese company Chugai Pharma has named Dr Athos Gianella-Borradori as chief medical officer of its US subsidiary. ... Cyclacel. The appointment at Chugai Pharma marks Dr Gianella-Borradori's first US role.

  • Chugai sets up antibody research company in Singapore

    Chugai sets up antibody research company in Singapore. Chugai Pharmabody Research will focus on generating new antibody drugs. ... Japanese pharma company Chugai is to set up a new research company based in Singapore.

  • A rush for sweet success

    US. Tramadol HCl extended-release tablets. RYZOLTTM (Purdue Pharma). Chronic pain. US. ... The GLP-1 pipeline includes five phase III compounds – albiglutide (Syncria, GSK, Human Genome Sciences), LY2189265 (Eli Lilly), taspoglutide (Roche, Chugai) and

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
McCann Health

The most globally awarded health agency network and currently Health Network agency of The Year. Comprising of two specialist agencies:...

Latest intelligence

Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....